200
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

A retrospective review of pregnancy outcomes in women with uncomplicated mild to moderate chronic hypertension

, ORCID Icon, , &
Pages 9071-9077 | Received 13 Aug 2021, Accepted 01 Dec 2021, Published online: 13 Dec 2021

References

  • Podymow T, August P. New evidence in the management of chronic hypertension in pregnancy. Semin Nephrol. 2017;37(4):398–403. [pii].
  • Seely EW, Ecker J. Chronic hypertension in pregnancy. Circulation. 2014;129(11):1254–1261.
  • Bramham K, Parnell B, Nelson-Piercy C, et al. Chronic hypertension and pregnancy outcomes: Systematic review and Meta-analysis. BMJ. 2014;348(apr15 7):g2301–g2301.
  • Panaitescu AM, Syngelaki A, Prodan N, et al. Chronic hypertension and adverse pregnancy outcome: a cohort study. Ultrasound Obstet Gynecol. 2017;50(2):228–235.
  • Panaitescu AM, Baschat AA, Akolekar R, Syngelaki A, et al. Association of chronic hypertension with birth of small-for-gestational-age neonate. Ultrasound Obstet Gynecol. 2017;50(3):361–366.
  • Broekhuijsen K, Ravelli AC, Langenveld J, et al. Maternal and neonatal outcomes of pregnancy in women with chronic hypertension: a retrospective analysis of a national register. Acta Obstet Gynecol Scand. 2015;94(12):1337–1345.
  • ACOG practice bulletin no. 203: Chronic hypertension in pregnancy. Obstet Gynecol. 2019;133(1):e26–e50.
  • Bateman BT, Bansil P, Hernandez-Diaz S, et al. Prevalence, trends, and outcomes of chronic hypertension: a nationwide sample of delivery admissions. Am J Obstet Gynecol. 2012;206(2):134.e1-134–e8.
  • American College of Obstetricians and Gynecologists, Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. report of the american college of obstetricians and gynecologists' task force on hypertension in pregnancy. Obstet Gynecol. 2013;122(5):1122–1131.
  • SMFM Publications Committee. SMFM statement: Benefit of antihypertensive therapy for mild-to-moderate chronic hypertension during pregnancy remains uncertain. Am J Obstet Gynecol. 2015;213(1):3–4.
  • Sibai BM, Mabie WC, Shamsa F, et al. A comparison of no medication versus methyldopa or labetalol in chronic hypertension during pregnancy. Am J Obstet Gynecol. 1990;162(4):960–966. discussion 966-7. [pii].
  • von Dadelszen P, Ornstein MP, Bull SB, et al. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a Meta-analysis. Lancet. 2000;355(9198):87–92. [pii].
  • Nakhai-Pour Hr RE, Berard A. Antihypertensive medication use during pregnancy and the risk of major congenital malformations or small-for-gestational-age newborns. Birth Defects Res B Dev Reprod Toxicol. 2010;89(2):147–154.
  • Olsen IE, Groveman SA, Lawson ML, et al. New intrauterine growth curves based on United States data. Pediatrics. 2010;125(2):e214-24–e224.
  • Magee LA, von Dadelszen P, Rey E, et al. Less-tight versus tight control of hypertension in pregnancy. N Engl J Med. 2015;372(5):407–417.
  • Abalos E, Duley L, Steyn DW, et al. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev. 2018;10:CD002252
  • Poon LC, Wright D, Rolnik DL, et al. Aspirin for evidence-based preeclampsia prevention trial: Effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history. Obstet Gynecol. 2017;217(5):585. e1–585. e5.
  • Nzelu D, Dumitrascu-Biris D, Nicolaides KH, et al. Chronic hypertension: First-trimester blood pressure control and likelihood of severe hypertension, preeclampsia, and small for gestational age. Am J Obstet Gynecol. 2018;218(3):337.e1–337.e7. [pii].
  • Dumitrascu-Biris D, Nzelu D, Dassios T, et al. Chronic hypertension in pregnancy stratified by first-trimester blood pressure control and adverse perinatal outcomes: a prospective observational study. Acta Obstet Gynecol Scand. 2021;100(7):1297–1304.
  • de Moraes R, Tibirica E. Early functional and structural microvascular changes in hypertension related to aging. Curr Hypertens Rev. 2017;13(1):24–32.
  • Rezk M, Ellakwa H, Gamal A, et al. Maternal and fetal morbidity following discontinuation of antihypertensive drugs in mild to moderate chronic hypertension: a 4-year observational study. Pregnancy Hypertens. 2016;6(4):291–294. [pii].
  • Magee LA, Dadelszen P, Singer J, et al.; the CHIPS Study Group. Do labetalol and methyldopa have different effects on pregnancy outcome? analysis of data from the control of hypertension in pregnancy study (CHIPS) trial. BJOG: Int J Obstet Gy. 2016;123(7):1143–1151.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.